Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a...
FY 2025
Dec 30, 2025
Q4 2025
Q4 2024
Dec 31, 2024
Q2 2024
Jun 30, 2024
Q4 2023
Dec 31, 2023